Cefiroxx-S 1.5 Injection
Marketer
Sunroxx Pharma
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Cefiroxx-S 1.5 Injection
Cefiroxx-S 1.5 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, regardless of symptom improvement. Premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and indigestion; worsening symptoms require immediate medical attention. Allergic reactions (rash, itching, swelling, dyspnea) necessitate urgent medical care. Inform your physician about all concurrent medications, and pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, drowsiness or dizziness mandates driving cessation. Rest, proper nutrition, and hydration promote recovery. Monitoring the medicine's effects may involve diagnostic testing.
Uses of Cefiroxx-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Cefiroxx-S 1.5 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cefiroxx-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefiroxx-S 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cefiroxx-S 1.5 Injection works:
Ceftriaxone and sulbactam, combined as Cefiroxx-S 1.5 Injection, offer a potent antibacterial approach. Ceftriaxone's antibiotic action disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Cefiroxx-S 1.5 Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Cefiroxx-S, 1.5 mg/mL, is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
The administration of Cefiroxx-S 1.5 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefiroxx-S 1.5 Injection may induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Cefiroxx-S 1.5 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Cefiroxx-S 1.5 Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult your physician for guidance. Dosage alteration for Cefiroxx-S 1.5 Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefiroxx-S 1.5 Injection :
Should you forget a scheduled Cefiroxx-S 1.5 Injection, seek medical advice.
Facts to Know About Cefiroxx-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently